Laboratory tests for heparin-induced thrombocytopenia: a multicenter study

Area of Science:

• Hematology
• Clinical Trials
• Diagnostic Assays

Background:

• Heparin-induced thrombocytopenia (HIT) is a serious immune complication of heparin therapy.
• HIT can progress to thrombosis (HITTS), necessitating accurate and timely diagnosis.
• Current diagnostic assays for HIT have limitations in sensitivity and specificity.

Purpose of the Study:

• To evaluate the utility of three diagnostic assays for HIT: platelet aggregation assay, serotonin release assay (SRA), and ELISA for heparin-platelet factor 4 (H-PF4) complex antibody.
• To compare the diagnostic performance of these assays in patients with HIT and HITTS.
• To determine if combining assay results improves diagnostic confirmation.

Main Methods:

• A multicenter clinical trial involving 199 patients with suspected HIT.
• Analysis of 512 to 606 samples using platelet aggregation assay, SRA, and H-PF4 complex antibody ELISA.
• Comparison of assay results in patients with and without thrombosis.

Main Results:

• Confirmation rates varied significantly: ELISA (64%) > SRA (55%) > platelet aggregation assay (26%).
• Patients with HITTS had higher confirmation rates than those with HIT alone.
• Combining all three assays increased positive response to 83%, but no direct correlation between assays was found.
• No minimum critical antibody titer could be identified, and clinically positive patients could be missed by all assays.

Conclusions:

• No single diagnostic assay is optimal for HIT confirmation.
• Combining platelet aggregation assay, SRA, and ELISA with multiple samples offers the best diagnostic chance.
• Caution is advised when interpreting results from individual or combined HIT assays due to potential for false negatives.